Metachronous tubulovillous and tubular adenomas of the anal canal by Hiroaki Nozawa et al.
CASE REPORT Open Access
Metachronous tubulovillous and tubular
adenomas of the anal canal
Hiroaki Nozawa1*, Soichiro Ishihara1, Teppei Morikawa2, Junichiro Tanaka1, Koji Yasuda1, Kensuke Ohtani1,
Takeshi Nishikawa1, Toshiaki Tanaka1, Tomomichi Kiyomatsu1, Kazushige Kawai1, Keisuke Hata1, Shinsuke Kazama1,
Hironori Yamaguchi1, Eiji Sunami1, Joji Kitayama1, Masashi Fukayama2 and Toshiaki Watanabe1
Abstract
Anal canal adenoma is an extremely rare disease that has the potential to transform into a malignant tumor. We
herein presented a rare case of metachronous multiple adenomas of the anal canal. A 48-year-old woman underwent
total colonoscopy following a positive fecal blood test. A 9-mm villous polyp arising from the posterior wall of the anal
canal was removed by snare polypectomy. Histologically, the tumor was tubulovillous adenoma with high-grade
dysplasia and the cut end was negative for tumor cells. Six years later, an elevated lesion, macroscopically five
millimeters in size, was detected in the left wall of the anal canal in a follow-up colonoscopy. Local excision of
the tumor was performed, and the lesion was pathologically confirmed to be tubular adenoma with high-grade
dysplasia limited to the mucosa. The patient is currently alive without any evidence of recurrence for six months
after surgery. Although she had a past history of cervical cancer, the multiple tumors arising in the anal canal
were unlikely to be related to human papilloma virus infection. Our case report underscores the importance of
careful observations throughout colonoscopy to detect precancerous lesions, particularly in anatomically narrow
segments.
Background
Anal canal tumors are a relatively uncommon occurrence
in the context of all intestinal neoplasms. The predominant
histology is the squamous cell type, whereas adenocarcin-
omas represent only 10 % of anal canal cancers [1–3], with
adenomas in this segment being even more infrequent [1].
We herein described a patient with multiple anal canal
adenomas that developed metachronously. Both lesions
limited within the mucosa were removed in minimally
invasive manners.
Case presentation
A 40-year-old woman visited the Gynecological Depart-
ment of our hospital with atypical genital bleeding for
one and a half years. She was diagnosed with cervical
cancer and subsequently underwent hysterectomy and
bilateral salpingo-oophorectomy. Pathology of the resected
cervix showed the non-keratinizing type of squamous cell
carcinoma, measuring 2.5 × 2.5 cm in size, without nodal
involvement (International Federation of Gynecology
and Obstetrics (FIGO) Stage IB1). Immunohistochemistry
revealed that the cancer cells were diffusely positive for
p16 (CDKN2A) (Fig. 1).
During the follow-up, she was referred to our depart-
ment at the age of 48 due to frequent anal bleeding after
bowel movements. Laboratory blood tests showed no
significant abnormalities; there were no signs of infection
with hepatitis or human immunodeficiency viruses, and
no elevations in the levels of the serum tumor markers
carcinoembryonic antigen and carbohydrate antigen 19–9.
A villous polyp was palpable on the posterior wall of the
anal canal by a digital rectal examination. The polyp was
just above the dentate line (Fig. 2a) and removed by snare
polypectomy. The lesion was 9 × 5 mm in size and histo-
logically diagnosed as tubulovillous adenoma with high-
grade dysplasia, and the cut end was negative for tumor
cells (Fig. 2b). Immunohistochemical staining revealed that
almost all tumor cells were positive for Caudal-related
Homeobox Transcription Factor 2 (CDX–2), whereas cyto-
keratin (CK)-7 staining was partially present. Moreover
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CK–20 immunoreactivity was only focally visible (data
not shown).
The colon was regularly checked every year thereafter.
At the age of 54, a follow-up colonoscopy showed an-
other elevated lesion that developed from the left wall of
the anal canal (Fig. 3a). The patient had anal discomfort
after each bowel movement. She underwent transanal re-
section of the tumor. A pathological examination revealed
tubular adenoma with high-grade dysplasia, approximately
five millimeters in size (Fig. 3b). Immunohistochemical
staining revealed that only a small number of tumor cells
were positive for p16 (CDKN2A) (Fig. 3c). The patterns of
CDX–2 and CK7/20 immunoreactivity were essentially the
same as the first anal adenoma (data not shown).
The patient has remained free of recurrence seven
months after tumor resection.
Conclusions
Primary anal canal neoplasms are relatively rare. The most
common histological type is squamous cell carcinoma that
originates from the distal epithelium of this segment. On
the other hand, adenocarcinomas only accounted for 10 %
of anal canal malignancies [1–3]. They include two sub-
types according to their origins: 1) mucosal-based adeno-
carcinomas that originate from colorectal-type epithelium
at the proximal end of the anal canal, and 2) extra-mucosal
adenocarcinomas arising from columnar epithelium lining
of anal glands which open into the transitional zone. The
latter is often associated with chronic fistulas [1–3].
Adenomas are distinctly rare entities in the anal canal;
only a limited number of cases have been reported to
date [4–7]. To the best of our knowledge, the present
case is the first report in the literature on multiple anal
canal adenomas. Based on the different directions of
the tumor origins and the tumor-free margin of the
first lesion, the two tumors are considered to have de-
veloped independently, and implantation of the first
adenoma as a cause of the second tumor was unlikely.
Furthermore, the CDX–2 positive phenotype indicates that
both lesions of the anal canal were mucosal-based tumors,
although the limited expressions of CK–7 and–20 were
not typical profiles of colorectal adenomas [8].
Several recent case reports showed that definite
adenocarcinomas arose from adenomas [6, 7]. These cases
support the concept that the adenoma-carcinoma se-
quence, which is well recognized in colorectal carcino-
genesis [9, 10], may be applicable to the development
of adenocarcinoma in the anal canal.
Multiple etiological factors have been suggested to
be associated with anal canal neoplasms such as anal
intercourse, human immunodeficiency virus infection,
and cigarette smoking [1, 11]. Furthermore, human
papillomavirus (HPV) has been strongly implicated as
a possible cause of tumorigenesis [12, 13]. Regarding
histology, several studies showed that 78–92 % of
squamous carcinomas and 40–43 % of adenocarcin-
omas were positive for HPV DNA [10, 14, 15]. Tachezy
et al. reported that HPV positivity was also observed in
Fig. 1 Immunohistochemical staining of p16 in cervical cancer
(original magnification: 200 ×). Bar indicates 100 μm
Fig. 2 Findings of the first anal canal tumor. a Endoscopic appearance. b Histological appearance of a low magnification (original magnification: 20 ×). The
border between adenoma and normal epithelium is indicated by a pair of arrowheads. Bar indicates 1 mm. The inset shows a higher-magnification view
(original magnification: 200 ×)
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40 % of anal canal adenomas [14]. Our patient had a
history of cervical cancer that was mostly linked to in-
fection by HPV [16]. Taken together, we imagined that
HPV infection might be a common cause of cervical cancer
and metachronous anal canal tumors. Since the expression
of p16 (CDKN2A), a cyclin-dependent kinase inhibitor, reli-
ably reflects the status of HPV infection in various anogeni-
tal and head and neck malignancies [17, 18], we performed
immunohistochemical staining of p16 in a resected speci-
men of the second anal canal tumor. However, immunore-
activity for p16 was negligible in the anal tumor cells, in
contrast to the diffuse positivity observed in the cervical
cancer cells. Our patient did not have other predispos-
ing risk factors such as familial adenomatous polyposis,
ulcerative colitis, or Crohn’s disease [4]. Therefore, we
could not identify specific factors that may account for
multiple tumorigenesis in the anal canal and cervix in
our patient.
The prognosis of anal canal cancers remains unsatisfac-
tory. The majority of these cancers are diagnosed in ad-
vanced stages that often require radical surgery such as
abdominoperineal resection [2, 3]. Although multidisciplin-
ary treatments have been introduced including surgery,
chemotherapy, and radiation therapy, the five-year overall
survival rate was estimated to be 39–63 % [2, 3, 19, 20].
Depth, lymph node metastases, histological grade, and
radical surgery were previously identified as prognostic
factors in anal canal cancers [2, 19, 21]. In our case, both
lesions in the anal canal were pre-malignant and confined
within the mucosa, suggesting a low risk of recurrence. Ac-
cordingly, the patient is now on follow-up without radiation
or chemotherapy.
The present case underscores the importance of careful
observations throughout colonoscopy to detect neoplastic
lesions in the narrow segment that may potentially acquire
an aggressive phenotype.
Fig. 3 Findings of the second anal canal tumor. a Endoscopic appearance. b Histological appearance of a low magnification (original
magnification: 40 ×). The border between adenoma and normal epithelium is indicated by an arrowhead. Bar indicates 1 mm. The inset
shows a higher-magnification view (original magnification: 200 ×). c Immunohistochemical staining of p16 in the second anal canal tumor
(original magnification: 200 ×). Only 4 % of tumor cells were positive for p16. Bar indicates 100 μm
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